The Healthcare Supply Chain Association (HSCA) is applauding U.S. Congress' passage of the Food and Drug Administration Safety and Innovation Act (S. 3187), which is designed to help avoid prescription drug shortages and facilitate the recall of faulty medical devices.
"We believe that the legislation will help address the prescription drug shortage issues confronting the healthcare supply chain, hospitals, and American patients and enhance the ability of the supply chain to track and recall faulty medical devices using a Unique Device Identifier (UDI)," stated HSCA President Curtis Rooney in a press release.
The HSCA also supports Congress in its efforts to require drug companies to provide FDA early notification of anticipated drug shortages, he added.
"With advanced notification provisions included in this law, FDA can act to relieve the pressures on the supply chain that lead to shortages," Rooney stated.
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
%20nov12024.q9h8imREpF.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
